4//SEC Filing
Encrantz Staffan 4
Accession 0000950170-23-066532
CIK 0001531177other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 8:32 PM ET
Size
12.0 KB
Accession
0000950170-23-066532
Insider Transaction Report
Form 4
Encrantz Staffan
Director10% Owner
Transactions
- Purchase
Common Stock
2023-11-24$3.09/sh+21,855$67,427→ 368,150 total - Purchase
Common Stock
2023-11-27$3.31/sh+246,331$815,947→ 614,481 total - Purchase
Common Stock
2023-11-28$3.46/sh+253,669$877,137→ 868,150 total
Holdings
- 1,184,258(indirect: See footnote)
Common Stock
- 4,022,118(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Reflects the weighted average price at which these shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased. The shares were purchased in multiple transactions at prices ranging from $2.96 to $3.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Reflects the weighted average price at which these shares of Common Stock were purchased. The shares were purchased in multiple transactions at prices ranging from $3.035 to $3.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]Reflects the weighted average price at which these shares of Common Stock were purchased. The shares were purchased in multiple transactions at prices ranging from $3.275 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]Includes 15,094 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2023 under the Issuer's Non-Employee Director Compensation Program, which are subject to vesting as previously reported. Each RSU represents a contingent right to receive one share of Common Stock.
- [F5]These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
- [F6]These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Sight Sciences, Inc.
CIK 0001531177
Entity typeother
Related Parties
1- filerCIK 0001870875
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 8:32 PM ET
- Size
- 12.0 KB